Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-Current Debt: 2020-2023

Historic Non-Current Debt for Bicycle Therapeutics (BCYC) over the last 4 years, with Dec 2023 value amounting to $30.7 million.

  • Bicycle Therapeutics' Non-Current Debt fell 72.13% to $8.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $8.5 million, marking a year-over-year decrease of 72.13%. This contributed to the annual value of $30.7 million for FY2023, which is 1.26% up from last year.
  • As of FY2023, Bicycle Therapeutics' Non-Current Debt stood at $30.7 million, which was up 1.26% from $30.3 million recorded in FY2022.
  • In the past 5 years, Bicycle Therapeutics' Non-Current Debt ranged from a high of $30.7 million in FY2023 and a low of $14.5 million during FY2020.
  • Over the past 3 years, Bicycle Therapeutics' median Non-Current Debt value was $30.3 million (recorded in 2022), while the average stood at $30.3 million.
  • Data for Bicycle Therapeutics' Non-Current Debt shows a peak YoY soared of 105.95% (in 2021) over the last 5 years.
  • Yearly analysis of 4 years shows Bicycle Therapeutics' Non-Current Debt stood at $14.5 million in 2020, then skyrocketed by 105.95% to $29.9 million in 2021, then rose by 1.48% to $30.3 million in 2022, then increased by 1.26% to $30.7 million in 2023.